Skip to main content
CELADON PHARMACEUTICALS PLC logo

CELADON PHARMACEUTICALS PLC — Investor Relations & Filings

Ticker · CEL ISIN · GB00BDQYGP38 LEI · 213800YXCATORT475807 IL Manufacturing
Open in API
Filings indexed 128 across all filing types
Latest filing 2022-03-30 Regulatory Filings
Country GB United Kingdom
Listing IL CEL

About CELADON PHARMACEUTICALS PLC

https://celadonpharma.co.uk/

Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The company operates a licensed, 100,000 sq ft facility with EU-GMP certification for the indoor, hydroponic cultivation of high-THC cannabis and the extraction of cannabinoid Active Pharmaceutical Ingredients (API). Its primary focus is the chronic pain market, and it is conducting an MHRA conditionally approved clinical trial to generate data supporting the use of its medicines for this condition. Additionally, Celadon has an in-house research and development program focused on intellectual property generation and is involved in developing a licensed cannabinoid treatment for Autism Spectrum Disorder through a biopharma partnership.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1942 characters) and contains the header 'RNS Number : 6554G' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, immediate market operational announcement. This type of brief, time-sensitive regulatory update that doesn't fit into the major financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS, as per the definitions and the 'MENU VS MEAL' rule (it's an announcement, not a detailed report).
2022-03-30 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1925 characters) and contains the header 'RNS Number : 6535G'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. This is a short, specific regulatory announcement that does not fit the definitions for major reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). Since it is a general regulatory announcement provided by RNS (the news service of the London Stock Exchange), the most appropriate classification is the general regulatory filing category.
2022-03-30 English
Change of Name
Regulatory Filings Classification · 100% confidence The document is a short announcement (2876 characters) released via RNS (RNS Number : 3693G) from the London Stock Exchange. The content explicitly states a 'Change of name' from Summerway Capital plc to Celadon Pharmaceuticals Plc, effective immediately. This is a general regulatory update concerning the company's identity on the exchange, not a detailed financial report (like 10-K or IR), a management change (MANG), or a specific transaction (POS, SHA). Since it is a formal, non-financial regulatory announcement distributed through the RNS system, and it doesn't fit into the more specific categories like DIRS, DIV, or DLST, the most appropriate classification is the general regulatory filing category.
2022-03-29 English
First Day of Dealings
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding the admission of Summerway Capital PLC (renamed Celadon Pharmaceuticals PLC) to the AIM market. It details the completion of an acquisition, a fundraising event, board changes, and the first day of trading. While it mentions an 'Admission Document', the text itself is a regulatory announcement of the event, not the document itself. Given the nature of the announcement covering capital changes, admission to trading, and corporate restructuring, it fits best under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2022-03-28 English
Result of General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement from Summerway Capital PLC regarding the 'Result of General Meeting'. It confirms that all resolutions were passed and directs readers to the company website for specific proxy vote details. This fits the definition of a Declaration of Voting Results (DVA).
2022-03-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2022-03-21 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.